Johnson & Johnson: U.S. regulators call for vaccine pause after blood clot reports

US recommends ‘pause’ in Johnson & Johnson vaccines after reports of blood clotsПодробнее

US recommends ‘pause’ in Johnson & Johnson vaccines after reports of blood clots

COVID-19: US halts Johnson & Johnson vaccine after rare blood clotsПодробнее

COVID-19: US halts Johnson & Johnson vaccine after rare blood clots

Covid: US regulators recommend 'pause' in use of Johnson & Johnson vaccine over blood clot reportsПодробнее

Covid: US regulators recommend 'pause' in use of Johnson & Johnson vaccine over blood clot reports

CDC and FDA recommend US pause use of Johnson & Johnson's COVID-19 vaccine over blood clot concernsПодробнее

CDC and FDA recommend US pause use of Johnson & Johnson's COVID-19 vaccine over blood clot concerns

US Regulators Recommend "Pause" On J&J Vaccine Over Rare Blood ClotsПодробнее

US Regulators Recommend 'Pause' On J&J Vaccine Over Rare Blood Clots

FDA and CDC call for 'pause' on Johnson & Johnson COVID-19 vaccine after blood clot reports | ABC7Подробнее

FDA and CDC call for 'pause' on Johnson & Johnson COVID-19 vaccine after blood clot reports | ABC7

U.S. Recommends 'Pause' for Johnson & Johnson Vaccine Over Blood Clot ReportsПодробнее

U.S. Recommends 'Pause' for Johnson & Johnson Vaccine Over Blood Clot Reports

Johnson & Johnson: U.S. regulators call for vaccine pause after blood clot reportsПодробнее

Johnson & Johnson: U.S. regulators call for vaccine pause after blood clot reports